Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.
Method Article
Ovariectomy and subsequent replacement of 17β-estradiol by means of silastic capsules and peroral Nutella are demonstrated in rats and mice.
Estrogens are a family of female sexual hormones with an exceptionally wide spectrum of effects. When rats and mice are used in estrogen research they are commonly ovariectomized in order to ablate the rapidly cycling hormone production, replacing the 17β-estradiol exogenously. There is, however, lack of consensus regarding how the hormone should be administered to obtain physiological serum concentrations. This is crucial since the 17β-estradiol level/administration method profoundly influences the experimental results1-3. We have in a series of studies characterized the different modes of 17β-estradiol administration, finding that subcutaneous silastic capsules and per-oral nut-cream Nutella are superior to commercially available slow-release pellets (produced by the company Innovative Research of America) and daily injections in terms of producing physiological serum concentrations of 17β-estradiol4-6. Amongst the advantages of the nut-cream method, that previously has been used for buprenorphine administration7, is that when used for estrogen administration it resembles peroral hormone replacement therapy and is non-invasive. The subcutaneous silastic capsules are convenient and produce the most stable serum concentrations. This video article contains step-by-step demonstrations of ovariectomy and 17β-estradiol hormone replacement by silastic capsules and peroral Nutella in rats and mice, followed by a discussion of important aspects of the administration procedures.
1. Ovariectomy via the Dorsal Route
2. Subcutaneous Administration of 17β-estradiol through Silastic Capsules
3. Peroral Administration of 17β-estradiol via the Nut-cream Nutella
4. Representative Results
Physiological serum 17β-estradiol concentrations, which the current methods aim to reproduce, are approximately 5-140 pg/mL for rats and 5-35 pg/mL for mice4,6. The subcutaneous silastic capsules according to the instructions above, when administered to 300 g female Sprague-Dawley rats, produce slowly decreasing 17β-estradiol serum concentrations from around 40 pg/mL day 2 to 10 pg/mL day 35. However, immediately after administration, a serum concentration peak around 1000 pg/mL can be expected, falling to the physiological range within 8 hours (Figure 1A)4,5. The silastic capsules for mice described above with 36 μg 17β-estradiol/mL, when administered to 25 g female C57BL/6 mice, render serum concentrations that slowly decrease from approximately 90 pg/mL day 2 to 25 pg/mL day 35. This is probably preceded by a similar peak as was found in the rats, although this has not been investigated (Figure 1B)6.
The peroral Nutella method with the dosages described above, when administered to 300 g female Sprague-Dawley rats, renders physiological levels of 17β-estradiol with daily fluctuations between 10-70 pg/mL (Figure 2A)4. For mice using the above dosage, the daily levels fluctuate between approximately 20 and 120 pg/mL (Figure 2B)6.
Figure 1. Stylized graphs presenting 17β-estradiol concentrations in rats (A; n=10 in time-points up to 24 h, n=15 in later time-points)4,5 and mice (B; n=10)6 after capsule implantation. The silastic capsules produce a short initial peak of serum concentrations up to 1000 pg/mL, but decrease within hours to levels below 100 pg/mL. For the coming 4-5 weeks, the capsules yield stable, although steadily decreasing, serum concentrations. The shaded areas correspond to physiological 17β-estradiol serum concentrations in intact female rats and mice respectively. Even though not visually demonstrated in the graphs, there is inter-individual variability in the 17β-estradiol concentrations, rendering coefficients of variation from 27 to 183 % in rats and from 28 to 115 % in mice with the silastic capsule method (very low mean concentrations often generate high coefficients of variation).
Figure 2. Stylized graphs presenting 17β-estradiol concentrations in rats (A; n=15)4 and mice (B; n=10)6 as a consequence of daily hormone administration in Nutella. The peroral Nutella method renders daily peaks, however not by far as high as produced by subcutaneous or intravenous methods. This mimics the pharmacokinetics of human hormone replacement therapy, and the peroral treatment can proceed for as long as needed, even if the example above only present an initial 96 hours. The shaded areas correspond to physiological 17β-estradiol serum concentrations in intact female rats and mice respectively. Even though not visually demonstrated in the graphs, there is inter-individual variability in the 17β-estradiol concentrations, rendering coefficients of variation from 40 to 132 % in rats and from 13 to 219 % in mice with the Nutella method (very low mean concentrations often generate high coefficients of variation).
Access restricted. Please log in or start a trial to view this content.
The administration modes presented above have in earlier studies proved superior to commercial slow-release pellets and injections in terms of producing physiological serum concentrations of 17β-estradiol. While the slow-release pellets produce very high and prolonged serum concentration peaks, the injections cause extreme, daily hormone fluctuations and require repeated stressful handling of the animals 4-6. The importance of choosing adequate administration modes is highlighted by recent studies indicat...
Access restricted. Please log in or start a trial to view this content.
The authors have nothing to disclose.
The study was funded by Linköping University and the County Council of Östergötland.
Access restricted. Please log in or start a trial to view this content.
Name | Company | Catalog Number | Comments |
Rimadyl, 50 mg/mL | Pfizer Pharma GmbH | 462986 | Postoperative analgesia after ovariectomy. |
Lubrithal eye gel | Leo Laboratories | Eye protection during surgery. | |
Jodopax vet | Pharmaxim | Surgery disinfection. | |
Vicryl 4-0 suture | Johnson & Johnson | Wound suture and ovary ligation. | |
17β-estradiol, >98% | Sigma-Aldrich | E8875-1G | In sesame oil for silastic capsules and Nutella. |
Sesame oil | Sigma-Aldrich | S3547-1L | Dissolving the 17β-estradiol. |
Silastic tubing, ID/OD: 1.575/3.175 mm | Dow Corning | 508-008 | Production of silastic capsules. |
Wooden applicator stick | Selefatrade | 12-0783 | Capping of silastic capsules. |
Nutella | Ferrero | Medium for peroral 17β-estradiol. |
Access restricted. Please log in or start a trial to view this content.
Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE
Zapytaj o uprawnieniaThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone